Literature DB >> 20206625

Role of chemokines in regulation of immunity against leishmaniasis.

Steve Oghumu1, Claudio M Lezama-Dávila, Angelica P Isaac-Márquez, Abhay R Satoskar.   

Abstract

Successful immunity to Leishmania depends on recruitment of appropriate immune effector cells to the site of infection and chemokines play a crucial role in the process. At the same time, Leishmania parasites possess the ability to modify the chemokine profiles of their host thereby facilitating establishment of progressive infection. Therapeutic and prophylactic strategies targeted at chemokines and their receptors provide a promising area for further research. This review highlights our current knowledge concerning the role of chemokines and their receptors in modulating leishmaniasis in both clinical settings and experimental disease models. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20206625      PMCID： PMC3661772          DOI： 10.1016/j.exppara.2010.02.010

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN： 0014-4894            Impact factor:   2.011


  81 in total

Review 1.  Balancing immunity and pathology in visceral leishmaniasis.

Authors:  Amanda C Stanley; Christian R Engwerda
Journal:  Immunol Cell Biol       Date:  2006-12-05       Impact factor: 5.126

Review 2.  Chemokines and their receptors: drug targets in immunity and inflammation.

Authors:  Antonella Viola; Andrew D Luster
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

3.  CCL2-independent role of CCR2 in immune responses against Leishmania major.

Authors:  M P Quinones; C A Estrada; F Jimenez; H Martinez; O Willmon; W A Kuziel; S K Ahuja; S S Ahuja
Journal:  Parasite Immunol       Date:  2007-04       Impact factor: 2.280

Review 4.  Pathophysiology of visceral leishmaniasis - some recent concepts.

Authors:  Nancy Malla; R C Mahajan
Journal:  Indian J Med Res       Date:  2006-03       Impact factor: 2.375

5.  CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice.

Authors:  Rene E Vasquez; Lynn Soong
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

6.  Protective immunity and delayed type hypersensitivity reaction are uncoupled in experimental Leishmania major infection of CCR6-negative mice.

Authors:  Anja Lechner; Uwe Ritter; Rosa Varona; Gabriel Marquez; Christian Bogdan; Heinrich Körner
Journal:  Microbes Infect       Date:  2006-12-27       Impact factor: 2.700

7.  Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection.

Authors:  René E Vasquez; Lijun Xin; Lynn Soong
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

8.  Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani.

Authors:  Joseph Barbi; Steve Oghumu; Lucia E Rosas; Tracy Carlson; Bao Lu; Craig Gerard; Claudio M Lezama-Davila; Abhay R Satoskar
Journal:  J Infect Dis       Date:  2007-04-16       Impact factor: 5.226

9.  Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.

Authors:  R Dey; N Majumder; S Bhattacharyya Majumdar; S Bhattacharjee; S Banerjee; S Roy; S Majumdar
Journal:  Scand J Immunol       Date:  2007-12       Impact factor: 3.487

10.  CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence.

Authors:  Ekaterina Yurchenko; Michael Tritt; Valerie Hay; Ethan M Shevach; Yasmine Belkaid; Ciriaco A Piccirillo
Journal:  J Exp Med       Date:  2006-10-02       Impact factor: 14.307
View more
  40 in total

1.  Leishmania donovani Lipophosphoglycan Increases Macrophage-Dependent Chemotaxis of CXCR6-Expressing Cells via CXCL16 Induction.

Authors:  Visnu Chaparro; Louis-Philippe Leroux; Aude Zimmermann; Armando Jardim; Brent Johnston; Albert Descoteaux; Maritza Jaramillo
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

2.  Regulatory T-Cell Dynamics in Cutaneous and Mucocutaneous Leishmaniasis due to Leishmania braziliensis.

Authors:  Nicolas Barros; Nestor Vasquez; Fernando Woll; Cesar Sanchez; Braulio Valencia; Alejandro Llanos-Cuentas; A Clinton White; Martin Montes
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

3.  The Src kinases Hck, Fgr and Lyn activate Arg to facilitate IgG-mediated phagocytosis and Leishmania infection.

Authors:  Dawn M Wetzel; Emma L Rhodes; Shaoguang Li; Diane McMahon-Pratt; Anthony J Koleske
Journal:  J Cell Sci       Date:  2016-06-29       Impact factor: 5.285

4.  Chronicity of dermal leishmaniasis caused by Leishmania panamensis is associated with parasite-mediated induction of chemokine gene expression.

Authors:  Adriana Navas; Deninson Alejandro Vargas; Marina Freudzon; Diane McMahon-Pratt; Nancy Gore Saravia; María Adelaida Gómez
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

5.  Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response.

Authors:  Paulo R Machado; Maria Elisa A Rosa; Diego Costa; Moema Mignac; João S Silva; Albert Schriefer; Mauro M Teixeira; Olivia Bacellar; Edgar M Carvalho
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-07-02       Impact factor: 2.184

6.  Mechanisms of immune evasion in leishmaniasis.

Authors:  Gaurav Gupta; Steve Oghumu; Abhay R Satoskar
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

7.  Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria.

Authors:  E Ayimba; J Hegewald; A Y Ségbéna; R G Gantin; C J Lechner; A Agosssou; M Banla; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

8.  Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.

Authors:  Steve Oghumu; James C Stock; Sanjay Varikuti; Ran Dong; Cesar Terrazas; Jessica A Edwards; Chad A Rappleye; Ariel Holovatyk; Arlene Sharpe; Abhay R Satoskar
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

9.  Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.

Authors:  Henry W Murray; Andrew D Luster; Hua Zheng; Xiaojing Ma
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

10.  Immunomodulatory effects of therapeutic plasma exchange on monocytes in antiphospholipid syndrome.

Authors:  Anush Martirosyan; Martin Petrek; Amit Kishore; Gayane Manukyan
Journal:  Exp Ther Med       Date:  2016-06-08       Impact factor: 2.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.